Hospira unveils plans to acquire injectable company

Article

Hospital products giant Hospira Inc., based in Lake Forrest, Ill., announced that it will acquire Australia?s Mayne Pharma Limited for $2 billion.

Hospital products giant Hospira Inc., based in Lake Forrest, Ill., announced that it will acquire Australia’s Mayne Pharma Limited for $2 billion. Executives on both sides believe that the Hospira/Mayne combo will be a good fit strategically and establish Hospira as the worldwide leader in generic injectable pharmaceuticals. Mayne Pharma is a market leader in Europe and Australia and has a significant presence in Canada. Hospira expects the alliance to strengthen its global reach. Hospira, the hospital products division of Abbott Laboratories, is a global specialty pharmaceutical and medication delivery company.

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.